Status:
COMPLETED
Trancutaneous Monitoring to Avoid Hypercapnea During Complex Catheter Ablations
Lead Sponsor:
The Cleveland Clinic
Conditions:
Hypercapnia
Eligibility:
All Genders
Brief Summary
Use of trancutaneous CO2 (TC02) monitoring to aide in titration of sedation of midazolam and fentanyl. Trancutaneous readings validated with invasively obtained specimens from existing arterial sheath...
Detailed Description
Cardiac electrophysiology procedures are typically performed under moderate (conscious) sedation in most centers. Advantages over general anesthesia include facilitating arrhythmia induction, avoidanc...
Eligibility Criteria
Inclusion
- Patients undergoing catheter ablation for atrial fibrillation (AF) or ventricular tachycardia (VT) under moderate sedation.
Exclusion
- Procedures scheduled for general anesthesia
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01815034
Start Date
March 1 2013
End Date
July 1 2013
Last Update
August 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195